Voyager Therapeutics (VYGR) Change in Acquisitions & Divestments (2015 - 2026)

Voyager Therapeutics (VYGR) has 12 years of Change in Acquisitions & Divestments data on file, last reported at $51.6 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments fell 56.6% year-over-year to $51.6 million; the trailing twelve-month figure through Mar 2026 stood at $336.8 million (up 14.46% YoY), and the FY2025 full-year result was $262.0 million, down 30.02% from the prior year.
• Change in Acquisitions & Divestments fell to $51.6 million in Q1 2026, from $118.8 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $118.8 million in Q1 2025 to a low of $5.0 million in Q2 2023.
• A 5-year average of $47.6 million and a median of $33.3 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
• Across the five-year window, Change in Acquisitions & Divestments jumped 632.85% in 2024 and plunged 56.6% in 2026, its largest moves.
• Tracing VYGR's Change in Acquisitions & Divestments over 5 years: stood at $15.0 million in 2022, then jumped by 277.21% to $56.6 million in 2023, then jumped by 94.28% to $109.9 million in 2024, then increased by 8.06% to $118.8 million in 2025, then sank by 56.6% to $51.6 million in 2026.
• Business Quant data shows VYGR's Change in Acquisitions & Divestments at $51.6 million in Q1 2026, $118.8 million in Q1 2025, and $109.9 million in Q1 2024.